ide-cel
FDA Approves New Indication for Abecma in Multiple Myeloma
The FDA approved Abecma for adult patients with relapsed or refractory multiple myeloma after two or more prior ...
APRIL 10, 2024
FDA Approves First Cell-Based Gene Therapy for Multiple Myeloma
The FDA approved Abecma to treat adults with relapsed or refractory multiple myeloma who have received at least ...
MARCH 31, 2021
Load more